An American Biotech company has just received ethical permission to conduct experiments on 20 clinically dead patients in an effort to jump start the brain. All of the subjects will be patients who are legally dead and kept alive only by machines, with the permission of that patient’s guardian or decision maker. They will have their brains monitored as different experiments are used in an effort to see if humans can have their brains regenerated.
Scientists will use a combination of therapies, which include injecting the brain with stem cells and a cocktail of peptides, as well as deploying lasers and nerve stimulation techniques which have been shown to bring patients out of comas.
The trial participants will have been certified dead and only kept alive through life support. They will be monitored for several months using brain imaging equipment to look for signs of regeneration, particularly in the upper spinal cord – the lowest region of the brain stem which controls independent breathing and heartbeat.
The team believes that the brain stem cells may be able to erase their history and re-start life again, based on their surrounding tissue – a process seen in the animal kingdom in creatures like salamanders who can regrow entire limbs.
Bioquark Inc. is the company granted permission to do the experiments. Their CEO, Dr ira Pastor says:
“This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime.”
“We just received approval for our first 20 subjects and we hope to start recruiting patients immediately from this first site – we are working with the hospital now to identify families where there may be a religious or medical barrier to organ donation.”
“To undertake such a complex initiative, we are combining biologic regenerative medicine tools with other existing medical devices typically used for stimulation of the central nervous system, in patients with other severe disorders of consciousness.”
“We hope to see results within the first two to three months.”
Dr Sergei Paylian, Founder, President, and Chief Science Officer of Bioquark Inc added:
“Through our study, we will gain unique insights into the state of human brain death, which will have important connections to future therapeutic development for other severe disorders of consciousness, such as coma, and the vegetative and minimally conscious states, as well as a range of degenerative CNS conditions, including Alzheimer’s and Parkinson’s disease.”
There is almost no possibility that scientists can reanimate Hillary before the November elections.